Security key
14888U101
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 66,576,359
- Share change
- -4,273,469
- Total reported value
- $222,408,153
- Put/Call ratio
- 133%
- Price per share
- $3.34
- Number of holders
- 131
- Value change
- -$12,651,094
- Number of buys
- 54
- Number of sells
- 71
Report period
Q4 2020
Institutions
131
Top holders
10
CPRX full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
CATALYST PHARMACEUTICALS, INC. SEC filings
CATALYST PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14888U101
Recent filing periods:
Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
8.1%
|
10,000,000
|
$29,700,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
6.2%
|
7,632,352
|
$22,668,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.1%
|
7,469,297
|
$22,184,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
4,948,156
|
$14,696,000 | — | 30 Sep 2020 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
2.5%
|
3,031,965
|
$9,005,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
2.3%
|
2,780,077
|
$8,257,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.1%
|
2,531,488
|
$7,518,000 | — | 30 Sep 2020 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
2%
|
2,447,837
|
$7,270,000 | — | 30 Sep 2020 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.4%
|
1,784,890
|
$5,301,000 | — | 30 Sep 2020 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1.3%
|
1,594,237
|
$4,734,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,547,958
|
$4,597,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,329,631
|
$3,949,000 | — | 30 Sep 2020 | |
| Man Group plc |
13F
|
Company |
0.92%
|
1,135,062
|
$3,371,000 | — | 30 Sep 2020 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.83%
|
1,027,387
|
$3,134,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
900,298
|
$2,674,000 | — | 30 Sep 2020 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
849,532
|
$2,523,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.6%
|
734,292
|
$2,181,000 | — | 30 Sep 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.57%
|
698,327
|
$2,073,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.56%
|
688,008
|
$2,209,000 | — | 30 Sep 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.56%
|
687,234
|
$2,043,000 | — | 30 Sep 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.51%
|
632,832
|
$1,879,000 | — | 30 Sep 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.39%
|
474,400
|
$1,409,000 | — | 30 Sep 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.37%
|
455,804
|
$1,353,000 | — | 30 Sep 2020 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.37%
|
449,680
|
$1,336,000 | — | 30 Sep 2020 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0.35%
|
432,864
|
$1,286,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.35%
|
430,333
|
$1,278,000 | — | 30 Sep 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.33%
|
407,643
|
$1,211,000 | — | 30 Sep 2020 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.32%
|
388,385
|
$1,154,000 | — | 30 Sep 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.31%
|
383,547
|
$1,139,000 | — | 30 Sep 2020 | |
| Wealthspire Advisors, L.P. |
13F
|
Company |
0.27%
|
337,770
|
$1,003,000 | — | 30 Sep 2020 | |
| Wealthspire Advisors, LLC |
13F
|
Company |
0.27%
|
337,770
|
$1,003,000 | — | 30 Sep 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.25%
|
306,046
|
$910,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.25%
|
303,682
|
$902,000 | — | 30 Sep 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.24%
|
296,980
|
$882,000 | — | 30 Sep 2020 | |
| HANCOCK WHITNEY CORP |
13F
|
Company |
0.24%
|
293,220
|
$871,000 | — | 30 Sep 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.23%
|
278,610
|
$867,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
275,850
|
$819,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.22%
|
272,714
|
$810,000 | — | 30 Sep 2020 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.22%
|
268,682
|
$798,000 | — | 30 Sep 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.22%
|
266,899
|
$791,000 | — | 30 Sep 2020 | |
| TANAKA CAPITAL MANAGEMENT INC |
13F
|
Company |
0.2%
|
252,199
|
$749,000 | — | 30 Sep 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.2%
|
243,316
|
$723,000 | — | 30 Sep 2020 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.19%
|
236,936
|
$704,000 | — | 30 Sep 2020 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.19%
|
233,330
|
$693,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.19%
|
229,480
|
$682,000 | — | 30 Sep 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.18%
|
224,074
|
$665,000 | — | 30 Sep 2020 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.18%
|
221,358
|
$657,000 | — | 30 Sep 2020 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
219,300
|
$651,000 | — | 30 Sep 2020 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.17%
|
212,303
|
$631,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
210,189
|
$625,000 | — | 30 Sep 2020 |
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q4 2020
As of 31 Dec 2020,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,576,359 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, PRUDENTIAL FINANCIAL INC, ROYCE & ASSOCIATES LP, HealthInvest Partners AB, GEODE CAPITAL MANAGEMENT, LLC, and LSV ASSET MANAGEMENT.
This page lists
131
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
140
Q4 2020 holders
131
Holder diff
-9
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.